Hyperion Therapeutics, Inc.
(NASDAQ : HPTX)

( )
HPTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.02%179.520.7%$1379.88m
MRKMerck & Co., Inc. -0.36%92.090.7%$1224.72m
PFEPfizer Inc. -1.03%51.750.9%$1105.43m
LLYEli Lilly & Co. -0.84%322.001.1%$1027.42m
BMYBristol-Myers Squibb Co. -0.36%76.601.0%$1002.11m
ABBVAbbVie, Inc. -0.18%153.531.9%$969.04m
AZNAstraZeneca Plc -2.05%64.601.0%$457.19m
SGENSeagen Inc. -0.64%178.955.7%$335.95m
GSKGSK Plc -1.46%43.110.2%$274.72m
TPTXTurning Point Therapeutics, Inc. -0.20%74.960.0%$202.43m
NVSNovartis AG -0.85%83.640.2%$171.13m
HZNPHorizon Therapeutics Plc 0.00%80.845.4%$170.59m
MRTXMirati Therapeutics, Inc. 0.00%71.181.6%$152.78m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%148.258.1%$149.37m
NVONovo Nordisk A/S -3.16%108.100.1%$137.44m

Company Profile

Hyperion is a biotech company developing therapies to address ''orphan or underserved patient populations.'' They are located in South San Francisco, CA.